Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Amikacin Treatment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03038178
What this trial is testing

Liposomal Amikacin for Inhalation (LAI) in the Treatment of Mycobacterium Abscessus Lung Disease

Who this might be right for
Mycobacterium Infections, NontuberculousMycobacteria, Atypical
Kevin Winthrop 30
Large-scale testing (Phase 3)Ended earlyNCT06418711
What this trial is testing

ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension

Who this might be right for
MAC Lung DiseaseTreatment Refractory MAC Lung DiseaseMycobacterium Infections, Nontuberculous
Mannkind Corporation 132
Testing effectiveness (Phase 2)Looking for participantsNCT06585020
What this trial is testing

Amikacin Liposome Inhalation Suspension for Treatment of Mycobacterium Xenopi Pulmonary Infection

Who this might be right for
Mycobacterium; XenopiLung Diseases
Centre Hospitalier Universitaire, Amiens 190
Post-approval studies (Phase 4)Study completedNCT07369336
What this trial is testing

Clinical Outcomes of Inhaled Amikacin in Ventilator Associated Pneumonia

Who this might be right for
Ventilator Associated Pneumonia ( VAP)
Postgraduate Medical Institute, Lahore 90
Not applicableUnknownNCT03990467
What this trial is testing

Observed Pharmacokinetic of Piperacillin/Tazobactam Compared to Amikacin in ICU

Who this might be right for
Septic ShockSepsisSepsis Syndrome
Hospices Civils de Lyon 60
Testing effectiveness (Phase 2)Study completedNCT00000641
What this trial is testing

A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium Avium Infection in HIV-Infected Individuals.

Who this might be right for
Mycobacterium Avium-intracellulare InfectionHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 90
Post-approval studies (Phase 4)Ended earlyNCT02872272
What this trial is testing

Amikacin Pharmacokinetic Profile in Plasma and Tissue After an Administration Using Impregnated Dressings in Burned Patient Population

Who this might be right for
Burn Patients
Assistance Publique Hopitaux De Marseille 7
Testing effectiveness (Phase 2)UnknownNCT05555303
What this trial is testing

Preventing Acquired Resistance: Strengthen TB Treatment by Adding Amikacin in the First Treatment Week of Multidrug-resistant Tuberculosis

Who this might be right for
Tuberculosis, Multidrug-Resistant
Rwanda Biomedical Centre 20
Testing effectiveness (Phase 2)Study completedNCT01969799
What this trial is testing

Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia

Who this might be right for
Pneumonia, Bacterial
Cardeas Pharma 143
Post-approval studies (Phase 4)Study completedNCT02081963
What this trial is testing

Combined Administration of Nebulized Amikacin in Patients With Acute Exacerbation of Non-Cystic Fibrosis Bronchiectasis

Who this might be right for
Non-Cystic Fibrosis Bronchiectasis
Qilu Hospital of Shandong University 178
Testing effectiveness (Phase 2)Study completedNCT01004445
What this trial is testing

Determine the Correct Dose of Amikacin Which is Delivered Directly to the Lungs of Ventilated Patients as an Aerosol Via an Investigational Device Called the Pulmonary Delivery Device System (PDDS)

Who this might be right for
Pneumonia
Bayer 69